Covid-19 Update

Graham Brady Excerpts

Monday 29th November 2021 Commons Chamber

[Sajid Javid]

First, I think it is fair to say that our genomics surveillance has never been so strong. It was getting stronger even before the pandemic, but because of the pandemic, there has been a huge amount of investment, and it has paid off UK-wide. On the treatments, there is some concern about this new variant and Ronapreve, which is one of the key monoclonal antibodies that we use for treatment, but it is just concern at this point; there is no particular evidence. However, part of the reason for taking these measures is to buy the time we need—two to three weeks—to give our scientists time to assess the risk of this variant properly.

[Sir Graham Brady (Altrincham and Sale West) (Con)]

First, what assessment has the Secretary of State made of the early reports from South Africa that the variant may actually lead to less severe illness than the previous variants? Secondly, I welcome the fact that we will have both a debate and vote tomorrow on these regulations, but would it not be better if we had the debate and the vote before the restrictions come into force, rather than after?

[Sajid Javid]

I believe that right after my statement the Leader of the House will be making a statement about the debate and vote tomorrow.

On the severity, there are reports, as my hon. Friend has said, but it is early days and we are looking into them, talking with our South African friends and getting more details. It is worth pointing out the difference in age profile and demographics: in South Africa, people with covid are on average younger, and we are taking that into account as well.